Chengqian Ye

2PUBLICATIONS
0CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Carbon capture engineering (excl. sequestration)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jun 19, 2026
Comment on: Real-world outcomes of ustekinumab, vedolizumab, and tumor necrosis factor inhibitors in very-early-onset inflammatory bowel disease.

|Apr 16, 2026
For Intermediate-Size Sessile Serrated Lesions, Durable Clearance Should Remain the Decisive Endpoint.

Pageof 1

Frequent Collaborators